Next Article in Journal
Transcriptome Changes during the Life Cycle of the Red Sponge, Mycale phyllophila (Porifera, Demospongiae, Poecilosclerida)
Next Article in Special Issue
Characterization of DNA Methylation in Circulating Tumor Cells
Previous Article in Journal / Special Issue
Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients
Review

Current and Future Prospects for Epigenetic Biomarkers of Substance Use Disorders

1
Department of Psychiatry, University of Iowa, Iowa City, IA 52242, USA
2
Department of Biomedical Engineering, University of Iowa, Iowa City, IA 52242, USA
3
Department of Psychology, University of Georgia, Athens, GA 30602, USA
4
Center for Family Research, University of Georgia, Athens, GA 30602, USA
*
Author to whom correspondence should be addressed.
Academic Editors: Jeffrey Craig and Thomas Mikeska
Received: 27 July 2015 / Revised: 16 September 2015 / Accepted: 22 September 2015 / Published: 14 October 2015
(This article belongs to the Special Issue Epigenetic Biomarkers)
Substance abuse has an enormous impact on economic and quality of life measures throughout the world. In more developed countries, overutilization of the most common forms of substances of abuse, alcohol and tobacco, is addressed primarily through prevention of substance use initiation and secondarily through the treatment of those with substance abuse or dependence. In general, these therapeutic approaches to substance abuse are deemed effective. However, there is a broad consensus that the development of additional tools to aid diagnosis, prioritize treatment selection and monitor treatment response could have substantial impact on the effectiveness of both substance use prevention and treatment. The recent demonstrations by a number of groups that substance use exposure is associated with robust changes in DNA methylation signatures of peripheral blood cells suggests the possibility that methylation assessments of blood or saliva could find broad clinical applications. In this article, we review recent progress in epigenetic approaches to substance use assessment with a particular emphasis on smoking (and alcohol) related applications. In addition, we highlight areas, such as the epigenetics of psychostimulant, opioid and cannabis abuse, which are markedly understudied and could benefit from intensified collaborative efforts to define epigenetic biomarkers of abuse and dependence. View Full-Text
Keywords: biomarkers; epigenetics; substance use disorders; addiction; smoking; tobacco; alcohol; cannabis; opioids; psychostimulants biomarkers; epigenetics; substance use disorders; addiction; smoking; tobacco; alcohol; cannabis; opioids; psychostimulants
Show Figures

Figure 1

MDPI and ACS Style

Andersen, A.M.; Dogan, M.V.; Beach, S.R.H.; Philibert, R.A. Current and Future Prospects for Epigenetic Biomarkers of Substance Use Disorders. Genes 2015, 6, 991-1022. https://0-doi-org.brum.beds.ac.uk/10.3390/genes6040991

AMA Style

Andersen AM, Dogan MV, Beach SRH, Philibert RA. Current and Future Prospects for Epigenetic Biomarkers of Substance Use Disorders. Genes. 2015; 6(4):991-1022. https://0-doi-org.brum.beds.ac.uk/10.3390/genes6040991

Chicago/Turabian Style

Andersen, Allan M., Meeshanthini V. Dogan, Steven R.H. Beach, and Robert A. Philibert 2015. "Current and Future Prospects for Epigenetic Biomarkers of Substance Use Disorders" Genes 6, no. 4: 991-1022. https://0-doi-org.brum.beds.ac.uk/10.3390/genes6040991

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop